help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 17, 2006
Endocrinology, doi:10.1210/en.2006-0252
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/11/5452    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Presman, D. M.
Right arrow Articles by Pecci, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Presman, D. M.
Right arrow Articles by Pecci, A.

Submitted on February 23, 2006
Accepted on August 9, 2006

Melatonin inhibits glucocorticoid receptor nuclear translocation in mouse thymocytes

Diego M. Presman, Esteban Hoijman, Nora R. Ceballos, Mario D. Galigniana, and Adalí Pecci*

IFIBYNE-CONICET, Departamentos de Química Biológica, Fisiología, Biología Molecular y Celular and Biodivesidad y Biología Experimental, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires and Fundación Instituto Leloir, Buenos Aires, Argentina

* To whom correspondence should be addressed. E-mail: apecci{at}qb.fcen.uba.ar.

The antiapoptotic effect of melatonin (MEL) has been described in several systems. In particular, MEL inhibits glucocorticoid-mediated apoptosis. Our group has previously demonstrated that in the thymus, MEL inhibits the release of Cytochrome C from mitochondria and the dexamethasone (DEX)-dependent increase of bax mRNA levels. In this study we analyzed the ability of MEL to regulate the activation of the glucocorticoid receptor (GR) in mouse thymocytes. We found that, even though the methoxyindole does not affect the ligand binding capacity of the receptor, it impairs the steroid-dependent nuclear translocation of the GR, and also prevents transformation by blocking the dissociation of the 90-kDa heat shock protein, hsp90. Co-incubation of the methoxyindole with DEX did not affect the expression of a reporter gene in GR transfected Cos-7 cells nor in HC11 and L929 mouse cell lines that express Mel-1A and ROR{alpha} receptors. Therefore, the antagonistic effect of MEL seems to be specific for thymocytes, in a Mel 1A and ROR{alpha} independent manner. In summary, the present results suggest a novel mechanism for the antagonistic action of MEL on GR mediated effects, which involves the inhibition of hsp90 dissociation and the cytoplasmic retention of the GR.


Key words: glucocorticoids • melatonin • Hsp90







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society